A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Amgen Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 84,378 shares of AMGN stock, worth $27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
84,378
Previous 77,556 8.8%
Holding current value
$27 Million
Previous $22.1 Million 19.56%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $1.79 Million - $2.18 Million
6,822 Added 8.8%
84,378 $26.4 Million
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $321,837 - $388,498
-1,197 Reduced 1.52%
77,556 $22.1 Million
Q4 2023

Mar 05, 2024

SELL
$255.7 - $288.46 $45,003 - $50,768
-176 Reduced 0.22%
78,753 $22.7 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $824,632 - $930,283
3,225 Added 4.26%
78,929 $22.7 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $1.78 Million - $2.21 Million
-8,123 Reduced 9.69%
75,704 $20.3 Million
Q2 2023

Dec 12, 2023

BUY
$214.27 - $253.37 $1.74 Million - $2.06 Million
8,123 Added 10.73%
83,827 $18.6 Million
Q2 2023

Aug 08, 2023

BUY
$214.27 - $253.37 $970,000 - $1.15 Million
4,527 Added 5.71%
83,827 $18.6 Million
Q1 2023

Dec 12, 2023

BUY
$225.79 - $275.2 $981,960 - $1.2 Million
4,349 Added 5.74%
80,053 $19.4 Million
Q1 2023

May 01, 2023

SELL
$225.79 - $275.2 $8,354 - $10,182
-37 Reduced 0.05%
79,300 $19.2 Million
Q4 2022

Feb 03, 2023

BUY
$229.03 - $291.01 $379,502 - $482,203
1,657 Added 2.13%
79,337 $20.8 Million
Q3 2022

Nov 08, 2022

SELL
$224.46 - $253.15 $65,542 - $73,919
-292 Reduced 0.37%
77,680 $17.5 Million
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $313,304 - $348,652
1,358 Added 1.77%
77,972 $19 Million
Q1 2022

May 05, 2022

SELL
$219.27 - $242.57 $527,563 - $583,623
-2,406 Reduced 3.04%
76,614 $18.5 Million
Q4 2021

Feb 02, 2022

BUY
$198.88 - $227.6 $697,869 - $798,648
3,509 Added 4.65%
79,020 $17.8 Million
Q3 2021

Oct 26, 2021

SELL
$212.27 - $248.7 $512,207 - $600,113
-2,413 Reduced 3.1%
75,511 $16.1 Million
Q2 2021

Jul 27, 2021

BUY
$233.58 - $259.14 $1.19 Million - $1.32 Million
5,106 Added 7.01%
77,924 $19 Million
Q1 2021

Apr 27, 2021

BUY
$221.91 - $258.6 $89,429 - $104,215
403 Added 0.56%
72,818 $18.1 Million
Q4 2020

Jan 29, 2021

BUY
$216.38 - $257.67 $157,957 - $188,099
730 Added 1.02%
72,415 $16.7 Million
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $784,434 - $872,355
3,343 Added 4.89%
71,685 $18.2 Million
Q2 2020

Aug 07, 2020

BUY
$197.81 - $242.74 $70,815 - $86,900
358 Added 0.53%
68,342 $16.1 Million
Q1 2020

Apr 28, 2020

SELL
$182.24 - $241.7 $8.53 Million - $11.3 Million
-46,782 Reduced 40.76%
67,984 $13.8 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $9.9 Million - $12.7 Million
-52,321 Reduced 31.31%
114,766 $27.7 Million
Q3 2019

Oct 29, 2019

BUY
$174.11 - $208.62 $608,340 - $728,918
3,494 Added 2.14%
167,087 $32.3 Million
Q2 2019

Jul 30, 2019

BUY
$166.7 - $195.41 $688,137 - $806,652
4,128 Added 2.59%
163,593 $30.1 Million
Q1 2019

Apr 22, 2019

BUY
$180.87 - $203.88 $1.27 Million - $1.43 Million
7,033 Added 4.61%
159,465 $30.3 Million
Q4 2018

Jan 25, 2019

BUY
$178.4 - $208.25 $463,840 - $541,450
2,600 Added 1.74%
152,432 $29.7 Million
Q3 2018

Oct 24, 2018

BUY
$185.29 - $208.89 $153,049 - $172,543
826 Added 0.55%
149,832 $31.1 Million
Q2 2018

Jul 09, 2018

BUY
$166.05 - $186.51 $488,519 - $548,712
2,942 Added 2.01%
149,006 $27.5 Million
Q1 2018

May 11, 2018

SELL
$169.43 - $198.0 $4.7 Million - $5.49 Million
-27,721 Reduced 15.95%
146,064 $24.9 Million
Q1 2018

Apr 19, 2018

BUY
$169.43 - $198.0 $10.5 Million - $12.2 Million
61,698 Added 55.04%
173,785 $29.6 Million
Q4 2017

Jan 24, 2018

SELL
$168.79 - $188.59 $2.92 Million - $3.26 Million
-17,305 Reduced 13.37%
112,087 $19.5 Million
Q3 2017

Oct 17, 2017

BUY
$167.29 - $191.0 $21.6 Million - $24.7 Million
129,392
129,392 $24.1 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.